Concept-of-the-week

Initial Public Offerings (IPOs)

When a venture-backed company lists on a public exchange, founders, employees, and early investors are typically subject to lock-up agreements that restrict selling pre-IPO shares immediately after listing. In the U.S., 180 days is the most common period, though specific terms vary. An employee holding 10,000 vested shares may be unable to sell until the applicable lock-up expires.

The tax timing can compound the issue. A non-qualified stock option (NSO) holder generally recognizes ordinary income when the option is exercised, based on the spread between fair market value and exercise price. Restricted stock units (RSUs) are generally taxed when they vest and settle. This can create a timing mismatch: the tax liability may arise while shares remain locked up.

After lock-up expiry, affiliates - officers, directors, and 10%-plus shareholders - may also face Rule 144 restrictions on how much stock they can sell in any three-month period. Knowing both timelines - the lock-up window and the tax trigger - matters for planning liquidity after an IPO.

What we’re watching

Angle Health's raised $600M:

Angle Health's financing announcement has two parts: a $200 million Series C investment in the company at a $2.7 billion valuation, and a $400 million tender offer allowing existing shareholders, including employees, to sell shares to new investors.

The tender offer provides liquidity to existing shareholders rather than new capital to the company. Vitruvian Partners led the financing. TechCrunch reported that employees could participate in the tender offer.

For cap table holders: a primary financing and a shareholder liquidity event can appear under one headline. The $600 million total consists of $200 million invested in the company and $400 million in secondary share sales.

Source: Fierce Healthcare

Community Office Hours

Join our next Office Hours on walkthrough of Reports for Equity Awards

Equity award reports are at the heart of every ESOP plan, they show where your pool stands, what's been granted, and what it all means for your books. But with so many reports available, finding the right one can get overwhelming fast.

In this Office Hours session, we're breaking it all down. We'll walk you through the Equity Pool and Grants, Vesting, and Financial reports on EquityList, and answer your questions live. Whether you're a first-time founder or a finance leader managing equity at scale, this session will give you the clarity to get it right.

September 29 | Tuesday | 3 PM IST

This week’s highlights

  • TEKEVER raised $580M Series D at $6.4B led by UC Investments and Baillie Gifford (Source)

  • Temporal Technologies raised $550M Series E at $12.55B led by Lightspeed and Goldman Sachs (Source)

  • Factory raised $200M at $5B, backed by Sequoia and Insight Partners (Source)

  • Profound raised $180M Series D at $1.8B led by Sequoia and Kleiner Perkins (Source)

  • Arcee AI raised $150M Series B at $1B+ led by Vista Equity Partners (Source)

See you next week,

Team EquityList

Did you find this newsletter useful?

Login or Subscribe to participate